Search - tctmd.com

Displaying 381 - 400 of 465

Sort: Relevancy | Date

News Industry News

Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve

May 20, 2014

News Daily News

CT-Based Artery Assessment May Reduce Vascular Complications in Transfemoral TAVR

L.A. McKeown

May 06, 2014

News Industry News

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

April 30, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Daily News

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

Jason Kahn

March 06, 2014

News Daily News

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Jason Kahn

March 06, 2014

News Industry News

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

February 04, 2014

News Daily News

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Jason Kahn

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

News Industry News

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

November 24, 2013

News Industry News

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Industry News

Thoratec Acquires DuraHeart® II Ventricular Assist System

July 01, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

Advertisement

Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve

CT-Based Artery Assessment May Reduce Vascular Complications in Transfemoral TAVR

InspireMD Announces Voluntary Field Action for MGuard™ Prime EPS

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Edwards' SAPIEN XT Valve Approved in Europe for Transcatheter Mitral and Aortic Valve-in-Valve Procedures

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent and Proven Outcomes in Real-World Setting

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages

Two Trials to Assess TAVR in Moderate-Risk Patients

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Thoratec Acquires DuraHeart® II Ventricular Assist System

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content